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Menaquinol-fumarate oxidoreductaseThe complex II family of proteins includes succinate:quinone oxidoreductase (SQR) and quinol:fumarate
oxidoreductase (QFR). In the facultative bacterium Escherichia coli both are expressed as part of the aerobic
(SQR) and anaerobic (QFR) respiratory chains. SQR from E. coli is homologous to mitochondrial complex II
and has proven to be an excellent model system for structure/function studies of the enzyme. Both SQR and
QFR from E. coli are tetrameric membrane-bound enzymes that couple succinate/fumarate interconversion
with quinone/quinol reduction/oxidation. Both enzymes are capable of binding either ubiquinone or
menaquinone, however, they have adopted different quinone binding sites where catalytic reactions with
quinones occur. A comparison of the structures of the quinone binding sites in SQR and QFR reveals how the
enzymes have adapted in order to accommodate both benzo- and napthoquinones. A combination of
structural, computational, and kinetic studies of members of the complex II family of enzymes has revealed
that the catalytic quinone adopts different positions in the quinone-binding pocket. These data suggest that
movement of the quinone within the quinone-binding pocket is essential for catalysis.Medical Center, 4150 Clement
0x4416; fax:+1 415 750 6959.
).
B.V.Published by Elsevier B.V.1. Introduction
Members of the complex II family of enzymes are membrane-
bound protein complexes that couple the interconversion of succinate
and fumarate with the reduction of quinone or oxidation of quinol [1–
4]. Primary members of the complex II family of proteins include
succinate:quinone oxidoreductase (SQR) and quinol:fumarate oxido-
reductase (QFR) [1–3]. SQR, the only membrane-bound component of
the Krebs' cycle, catalyzes the oxidation of succinate to fumarate
during aerobic respiration, coupled with the reduction of quinone to
quinol within the membrane domain. SQR is present in the inner
mitochondrial membrane and plasmamembrane of many aerobic and
facultative bacteria such as Escherichia coli. QFR is found in anaerobic
or facultative bacteria and lower eukaryotes, where it couples the
oxidation of a variety of quinols with the reduction of fumarate as part
of an anaerobic respiratory chain [1–4]. Complex II enzymes are
usually composed of four distinct subunits with two encompassing a
hydrophilic domain attached to two membrane integral hydrophobic
subunits. There are exceptions, however, where the hydrophobic
subunits have fused to form a single transmembrane subunit [2–4] or
in the case of parasitic protists where up to six hydrophobic subunits
are present [5].
In this article we will focus on the prototypical complex IIs which
contain four subunits such as those found in the inner mitochondrialmembrane of mammals and in the facultative bacterium E. coli [1,3].
The overall structure of SQR (or E. coli QFR) (Fig. 1) is a hydrophilic
ﬂavoprotein subunit (SdhA for SQR or FrdA for QFR) containing a
covalently bound FAD cofactor and the dicarboxylate-binding site
interacting with an iron-sulfur protein subunit (SdhB, FrdB). The iron–
sulfur protein subunit contains three distinct Fe–S clusters ([2Fe–2S],
[4Fe–4S], [3Fe–4S]) arranged to form a linear electron transport chain
between the FAD cofactor to the quinone-binding site at the interface
of the membrane domain. At the interface between the two
hydrophobic membrane spanning (SdhC and SdhD or FrdC and
FrdD) subunits and the Fe–S protein lies the catalytic quinone-binding
site where quinone reduction/quinol oxidation occurs. In the case of
mammalian and E. coli SQR the SdhC and SdhD subunits also provide
the histidyl axial ligands for the low spin heme b present in complex II
[6,7]. QFR from E. coli is atypical for complex II family members in that
it lacks heme even though it is fully capable of catalyzing the same
reactions with quinones and/or dicarboxylates as heme containing
complex IIs [8–10]. It is of interest therefore, that recent mutational
studies of E. coli and yeast SQR have shown that the heme appears
dispensable for reaction with quinones within the membrane
environment although it does provide structural stability to the
enzyme [11,12].
The X-ray structures for the E. coli SQR [6] and QFR [8] were the
ﬁrst obtained for the respective members of the complex II family,
however, these structures were rapidly followed by high resolution
structures from the bacteriumWolinella succinogenes for QFR [13], and
mitochondrial SQRs from pig [7] and chicken [14,15]. The combination
of structures showed that the SdhA and SdhB subunits from all
Fig. 1. Structure of E. coli QFR and SQR. Left side: Shown is the overall structure of E. coli QFR (pdb 1LOV). The FrdA ﬂavoprotein subunit is shown in green, the FrdB Fe–S protein
subunit is shown in cyan, the FrdC transmembrane anchor protein is shown inmagenta, the FrdD transmembrane anchor protein is shown in blue. The FAD, [2Fe–2S], [4Fe–4S], [3Fe–
4S] redox centers are shown as red and yellow spheres. At the bottom the bluish area indicates the membrane domain. The two quinone molecules in QFR, QP and Qd are shown as
yellow spheres. Right side: Shows the overall structure of E. coli SQR (pdb 1NEK). The subunit and redox center coloring is the same as for the QFR molecule shown on the left. The
heme b is shown as yellow spheres near the quinone-binding site of SQR.
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W. succinogenes QFR were highly similar. There were differences,
however, in the structures of the transmembrane SdhC and SdhD
subunits compared to their QFR counterparts. It was found, however,
that amino acid residues that appear to be essential for interaction
with quinone were absolutely conserved in E. coli and the mitochon-
drial SQRs [6,7,15]. This makes E. coli SQR an excellent model system
for structure/function studies of complex II because of the high levels
of protein expression and the ease of genetic manipulation of the
bacterial enzyme.
A number of heterozygous mutations in the human SDHB, SDHC,
and SDHD genes which cause pheochromocytomas and paragan-
glioma tumor formation have been described (reviewed in [16]).
Recently a new gene termed SDH5 which is an assembly factor
required for the covalent-ﬂavination of SdhA has also been shown to
be associated with tumor formation [17] although the protein product
of this gene is not assembled into themature complex II. Nevertheless,
themajority of mutations associated with tumor formation in humans
are found in the SdhB, SdhC, and SdhD proteins whose proper
assembly is necessary to form the quinone-binding site of complex II
[1–3]. Therefore, characterization of the quinone-binding site is
important to our understanding of how complex II contributes to
disease in different human tissues. Belowwe discuss and compare the
quinone-binding sites of E. coli SQR with its mitochondrial counter-
parts and also with E. coli QFR.
2. Distal quinone binding site (QD) of E. coli QFR and pig SQR
Before any X-ray structures for complex II had become available
evidence for the heterogeneity of complex II bound ubisemiquinones
in the bovine enzyme was obtained by EPR [18,19]. These data
suggested that the two benzoquinone rings of ubiquinone (UQ) were
only 7.7 Å apart and perpendicular to the membrane plane [19,20].
Therefore, it was of interest that the initial publication of a structure
for any member of the complex II family was that for E. coli QFR at
3.3 Å [8] and in this structure two menaquinone (MQ) molecules on
opposite sides of the membrane were observed (Fig. 1, left side). Themenaquinone molecule near the periplasmic side of the membrane-
spanning FrdC and FrdD subunits was termed QD (for distal side).
Although the arrangement of two quinones on opposite sides of the
membrane-spanning region is reminiscent of the cytochrome bc1
[21,22] and photosynthetic reaction center [23,24] it was difﬁcult to
understand how the QD quinone could be involved in electron transfer
because of the large distance (∼27 Å) from its nearest redox center
the quinone proximal to the [3Fe–4S] cluster (QP) [1,3,8]. The
presence of the QD-site on the opposite side of the membrane was
also not consistent with the spatial proximity of the two ubisemiqui-
nones suggested to be present in bovine mitochondrial membranes
[18,19]. It is generally believed that nature has selected electron-
tunneling reactions in proteins to occur over a rather short range of 4–
14 Å [25]. The X-ray structure of E. coli QFR did not show any redox
center between the two menaquinone molecules that was capable of
mediating electron transfer [8] thus the role of the quinone at the QD
site was unclear. Mutational studies done with the E. coli QFR [10] and
yeast [26] and homology models [27] also suggested the potential for
two quinone binding sites. It was interest, therefore, when the ﬁrst
eukaryotic SQR structure (pig)was determined [7] that twomolecules
of the quinone-binding site inhibitor 2-thenoyltriﬂuoroacetone
(TTFA) were observed on opposite sides of the membrane-spanning
subunits in a 3.5 Å structure (pdb code 1ZPO) similar to the observed
menaquinone molecules in E. coli QFR. Although these data [7,8]
would seem to support the existence of two quinone binding sites in
members of the complex II family of proteins they must be taken with
caution. First, there was stronger electron density for the TTFA
molecule at the site proximal to the [3Fe–4S] cluster than that for the
second TTFA molecule at the site termed QD [7]. It was also noted that
the primary contacts for the TTFA molecule at QD were mainly
through two water molecules rather than through the protein
backbone and it was suggested that the binding of TTFA to this distal
site was much weaker than that at the proximal site [7]. Also the
second TTFA molecule in the pig SQR is 15 Å from the edge of the
heme b which as noted above is not in the range for productive
electron transfer reactions [7,25]. It could be argued that conforma-
tional changes in the SQR could move the QD site closer to the heme
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and E. coli SQR that the single heme b is not essential for electron
transfer [11,12]. Second, a more recent structure of E. coli QFR at 2.7 Å
in the presence of the quinone-site inhibitor 2-heptyl-4-hydroxy-
quinoline-N-oxide (HQNO) showed only a single HQNO molecule at
the QP-site, whereas, the site at QD was empty and ﬁlled with diffuse
density that probably was from a detergent or phospholipid molecule
[28]. Third, the highest resolution complex II structures currently
available (2.1 Å, pdb code 2FBW) from avian sources shows only a
single inhibitor present which is always at the quinone-binding site
proximal to the [3Fe–4S] cluster [15]. Fourth, E. coli SQR structures
also show only a single quinone-binding site even when crystallized
under a variety of conditions and with different inhibitors present
[6,29,30]. Fifth, extensive kinetic studies of both E. coli and bovine SQR
and QFR [3,9] are consistent with a single functional quinone-catalytic
site in the enzymes. It can now be suggested that the interpretation of
the kinetic data pointing towards the presence of the second quinone-
binding site may be due to the use of membrane-bound protein
complexes and assay systems that are based on primary (quinone)
and secondary electron acceptors (DCIP, MTT) used in the assays
[10,26]. It should also be noted, that in both the E. coli QFR [10] and
yeast [26] systems mutational analysis of the putative second
quinone-binding site showed that signiﬁcant quinone-reductase
activity remained in themutants suggesting that long range structural
alterations in the protein could account for the loss of activity. These
ﬁndings along with the long electron transfer distances from the
primary electron transfer chain of complex II suggest that the distal
quinone binding site seen in complex II enzymesmay result from non-
speciﬁc binding of inhibitors used at high concentrations during the
crystallization procedure.
It should be noted that the functional quinone-binding site of the
di-heme QFR fromW. succinogenes [31,32] and from the di-heme SQR
from Bacillus subtilis [33] is on the periplasmic side of the membrane.
The di-heme members of the complex II family do not have the
problem of the spatial distance between redox centers to allow
productive electron transfer to occur across the membrane domain.
The ﬁnding that the protonation/deprotonation of quinone occurs on
the positive side of the membrane (i.e., periplasmic space of gram
negative bacteria) also helps explain the coupling activity of the di-
heme SQR/QFR to the transmembrane electrochemical potential
[2,31–35] which does not occur in the prototypical E. coli SQR/QFR
or mammalian SQR.
The existence of the distal cavity capable of binding quinones may
indicate that remnants of an evolutionarily conserved second
quinone-binding site is present in complex II enzymes from a variety
of organisms [36], however, it would appear that there is only a single
functional quinone binding pocket that is proximal to the [3Fe–4S]
cluster in single heme b containing complex II enzymes, as seen in E.
coli and avian SQR and more recent QFR structures. The weak binding
of the Q-site inhibitor TTFA seen in the SQR pig structure (1ZPO) may
reﬂect the high concentration of inhibitor used during crystallization
and the evolutionary remnant of a Q-binding site in mammalian
complex II.
3. Common properties of the functional Q-sites of SQR and QFR
There are several similar features that deﬁne the quinone-binding
site in both SQR and QFR that are discussed below. It should be noted
that one difference is that E. coli QFR is atypical of complex II family
members in that it does not contain or require a b-type heme for
catalysis or its assembly although it is quite proﬁcient in catalysis with
both benzo- and napthoquinones [9]. In E. coli QFR the functional
quinone-binding cavity (Fig. 2A) occupies a position near the
cytoplasmic side of the membrane and involves amino acid residues
from the FrdB, FrdC, and FrdD polypeptides. The [3Fe–4S] center is 7 Å
(edge-to-edge) from the quinone binding site and separated by ashort loop between Cys204 and Cys210 of FrdB [8,28]. The best
current resolution for E. coli QFR structures is at 2.7 Å, therefore
waters have not been speciﬁcally placed in structures of the quinone-
binding site. Structures with both menaquinone and its analogue
HQNO show that they occupy similar positions in the quinone-
binding pocket and both carbonyl oxygens of the napthoquinone
establish H-bonding to the protein.
Similar to the functional quinone-binding site in QFR the SQR
binding site is formed by a pocket near the cytoplasmic interface
formed by amino acid residues from the SdhB, SdhC, and SdhD
subunits (Fig. 2B). One difference is the close proximity of the heme b
propionate to the site where quinone binds in SQRs from E. coli,
mammalian, and avian sources [6,7,15]. The E. coli SQR X-ray structure
has been determined with bound UQ (2.7 Å), and the quinone
inhibitor analogues, Atpenin A5 (2.6 Å), pentachlorophenol (PCP,
3.2 Å), DNP-17 (3.2 Å), carboxin (2.4 Å), and an empty UQ-binding
site (3.2 Å) [6,29,30]. Structures of mammalian (pig) complex II with
UQ (2.5 Å) and the inhibitor TTFA (3.2 Å) [7] and chicken SQRwith UQ
(2.4 Å), carboxin (2.1 Å), and an empty site [14,15] have also been
published. In all SQR structures fromwhatever source the same amino
acids function in binding of ubiquinone or inhibitors showing the high
degree of homology for the functional quinone-binding site from
prokaryotes to eukaryotes.
3.1. Interaction of quinones with catalytic sites in complex II
The chemical numbering for substitutions of benzo- and naptho-
quinone rings used in the discussion is as shown in Fig. 3. The
numbering used reﬂects the position of the isoprenoid tail to identify
each face of the quinone ring for UQ (2, 3-dimethoxy-5-methyl-6-
isoprenyl-1,4-benzoquinone), and MQ (5-methyl-6-isoprenyl-1,4-
napthoquinone).
Ubiquinone and MQ both show asymmetrical binding with a
stronger binding for the O1 atom compared to the O4 carbonyl oxygen
atom [6,28,37]. In both SQR and QFR there are two H-bonds to the O1
carbonyl oxygen atom with one amino acid from the Fe–S subunit
providing one bond and the other coming from an amino acid in the
transmembrane domain subunits. Each quinone-docking site consists
of a Trp (SdhB Trp164, FrdD Trp14) residue and a second amino acid
that normally has a high pKa in its free form (SdhD Tyr83, FrdB
Lys228). The Trp residue is found on the same plane of the face of the
quinone ring for either UQ or MQ [6–8,14,15,28,30]. One difference at
the primary sequence level is that in one case the Trp residue comes
from the hydrophobic domain subunit FrdD, whereas, in the other it
comes from the Fe–S protein SdhB but in the three dimensional
structure the Trp adopts the same conformation over the quinone
ring. There are additional hydrogen bond interactions between FrdB
Lys228, with Gln B225 and Cys B204; and SdhD Tyr83 with SdhC
Arg31 which likely decrease the pKa of these potential H-exchange-
able groups. Substitution of either SdhD Tyr83 or FrdB Lys228 has
severe effect on quinone-binding and catalytic activity, however, the
remaining Trp residue in each site was still sufﬁcient for residual
quinone-binding [37–39]. In QFR FrdD Trp14 appears to be important
to the site by creating a hydrophobicwall and by providing interaction
to the ﬁrst two isoprenoid units of MQ consistent with the Km for UQ
and MQ being an order of magnitude lower for quinones with two
isoprenoid units rather than one [9,37].
On the other side of the quinonemolecule where H+ exchange can
occur (the O1 carbonyl oxygen atom) FrdC Glu29 and SdhC Ser27 are
suggested as sites for proton acceptor/donors [8,29,37]. In the QFR
structure [8,28] FrdC Glu29 is clearlywithin H-bond distance to the O1
carbonyl oxygen of MQ, whereas, in the original SQR structure [6],
SdhC Ser27 is about 4.5 Å from the O4 carbonyl of UQ. Site-directed
substitution of these residues shows no effect on ligand bindingwhich
is consistent with strong asymmetric Q-binding via the O1 carbonyl.
Additional conﬁrmation of the E. coli QFR quinone-binding site was
Fig. 2. Functional quinone-binding site of QFR (A) and SQR (B). (A) View of the Q-site of E. coli QFR with the menasemiquinone analogue HQNO bound. The structure is drawn from
pdb ﬁle 1KF6 (2.7 Å). The HQNO is shown in green with the dashed lines to the O1 oxygen atom (which would be present in menaquinone) indicating H-bonds from Lys B228 and
Trp D14. Cys B204, Gln B225, and Lys B228 are shown in cyan, and Trp D14 in yellow. On the other side of the binding pocket Arg C28, Glu C29 and Arg D81 are shownwith the dashed
lines indicating H-bonds to the O4 oxygen atom. Arg C28 and Glu C29 are shown inmagenta, and Arg D81 in yellow. (B) View of the Q-binding site of E. coli SQRwith UQ bound at the
entry of the binding pocket. The structure is obtained from pdb ﬁle 1NEK (2.5 Å). The UQmolecule is shown in green with the dashed lines indicating H-bonds from Trp B164 and Tyr
D83 to the O1 oxygen atom of UQ. Trp D83 is shown in yellow and Trp B164 in cyan. Also shown are His B207 (cyan), Arg C31 (pink), and Asp D82 (yellow) which form H-bonds to a
conserved water molecule shown as a red sphere. Shown at the bottom of the ﬁgure is Ser C27 (magenta) which forms an H-bond to the O4 oxygen atom once the UQ hasmoved into
the catalytic position (not shown). In the catalytic position His B207 also forms a bond to the 3-methoxy group of the benzoquinone ring. In white and red to the left are shown one of
the heme propionates which are near the quinone-binding pocket in SQR.
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ysis. FTIR data showed that MQ carbonyl vibrational modes were
downshifted upon MQ binding to isolated QFR which is indicative forFig. 3.Model of the movement of quinones in the quinone-binding site of QFR and SQR. (Left
quinone catalytic site of E. coli QFR. At the bottom of the ﬁgure on the left is shown an MQm
chain at the six positions and the carbonyl positions 1 and 4. In the model it is shown tha
carbonyl forms bonds to Glu C29 and Arg C28. When UQ is present a similar arrangement of
swing into a position where the C4 carbonyl forms a bond with Arg C28 and not with Glu C2
side) The motion of UQwithin the quinone-binding pocket of SQR. At the bottom is a UQmo
methoxy groups of the benzoquinone ring. As discussed in the text the ﬁgure shows in green
H-bonds to Trp B164 and Tyr D83, however, there is no nearby residue to H-bond to the C4 ca
like movement occurs with the UQmoving to the catalytic position shown in blue. An H-bond
to the 3-methoxy group and through a water molecule (shown in red) to Arg C31 and Asp D
quinone within the binding pocket.strong hydrogen bonds to both menaquinol carbonyl groups with the
protein [37]. The observed signal was, however, split reﬂecting a
weaker binding of one of the C=O groups. The stronger binding wasside) On the left is shown the model of the movement of MQ (red) and UQ (blue) in the
olecule including the numbering systems used in the text indicating the isoprenoid side
t the C1 carbonyl of MQ forms strong H-bonds with Lys B228 and Trp D14 and the C4
H-bonds forms to the C1 carbonyl of UQ, however, a pendulum like motion causes UQ to
9 which only bonds to MQ. The gray arrow indicates the motion of the quinone. (Right
lecule indicating the numbering systems used in the discussion to note the carbonyl and
UQ docking to the entry site of the quinone binding pocket where the C1 carbonyl forms
rbonyl. Upon delivery of electrons from the [3Fe–4S] cluster a conformational pendulum
with Ser C27 is formed to the C4 carbonyl and there are also interactions with His B207
82 to the 2-methoxy group. The gray arrow indicates the pendulum like motion of the
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data are consistent with effects observed on binding of quinone
analogues. In QFR it was found that there was a 100-fold increase in
the Kd for HQNO binding in the FrdB Lys228Leu consistent with the
Lys residue acting as the normal ligand for the O1 carbonyl [37].
Using the E. coli SQR enzyme as the model [6] it is found that side
chains of SdhBTrp164 andSdhDTyr83 aredirect ligands of theO1atomof
UQ. SdhD Tyr83 forms and additional H-bondwith the side chain of SdhC
Arg31 which may lower the pKa of Tyr83 facilitating its ability to act as a
proton donor to UQ [6]. Other residues absolutely conserved and in the
vicinity of the O1 atom of UQ in the SQR family are polar residues SdhC
Arg31 and SdhD Asp82. Site directed mutants were constructed for both
the Arg31 (R31L) and Asp82 (D82L) residues and it was found that there
was a very severe affect on the enzymes ability to reduce UQ [38].
Conversely there was somewhat disparate results obtained when SdhD
Tyr83wasmutated in E. coli SQR [37] versuswhen the equivalent residue
was changed in yeast SQR [39]. The X-ray structures of SQR [6,7,14] show
the Tyr residue H-bonded to the O1 atom of UQ and when the Tyr was
mutated in the yeast enzyme an almost total loss of the enzymes ability to
reduce quinonewas found. This is consistent with the Tyr residue being a
direct proton donor to the quinone [39]. However, it was found that site-
directed mutants of E. coli SdhD Tyr83 retained 15–28% of wild-type
quinone reductase activity suggesting that some other residue or a water
molecule may act as the direct proton donor to UQ [38]. In subsequent
unpublished studies using puriﬁed isolated SQR we have found that the
Tyr83Phe mutation does have a signiﬁcant (∼28-fold) increase in the Km
for binding of UQ. The data in both yeast and E. coli SQR are in agreement
that Tyr83 plays an important role in the function of the quinone-binding
site although it may be that another residue or water molecule may
substitute as a direct proton donor to the O1 atom of UQ inmutant forms
of the enzyme. The differences between the yeast and E. coli SQR may
reﬂect the different ubiquinone analogues used for measurement of
quinone-reductaseactivity [38,39] or subtledifferences in thearchitecture
of the quinone binding site in the two organisms.
In theQFR FrdCGlu29Leumutant [37] there is a signiﬁcant rise in the
pKa of themenaquinol oxidase reaction supporting the role inwild-type
QFR that Glu29 is an H+-accepting residue [40]. In the wild-type QFR
structurewithHQNO [28] theO4 carbonyl of the inhibitor, in addition to
forming anH-bond to Glu29, is also 3.2 Å from FrdC Arg28which either
directly or via a water molecule may act as a proton acceptor in the
mutant enzymes that show a higher pKa for the menaquinol oxidase
reaction. In these samemutants, however, wheremenaquinol oxidation
is altered the kinetic parameters for quinone reduction are similar to
those of wild-type QFR [37]. There are several explanations for this
observation. First, lack of an effect of the Glu29Leu substitution on UQ
reduction is consistent with the suggestion that FrdC Arg28 may
directly, or via an H-bonded water molecule, participate in MQH2
oxidation anddeﬁne thehigh pKa of the reaction. Thus, Arg28may act as
a protondonor forUQ, in themutant suggesting that this partial reaction
is not rate limiting for UQ reduction. Alternatively, onemay suggest that
Glu29 may not be the direct proton donor for UQ, but rather interacts
with the 3-methoxy group of the ubiquinone ring. Thiswould result in a
3–4 Å shift in the position of the UQ ring towards the entry of the Q-
binding site that would establish an H-bond between the O4 atom and
Arg28 while keeping the O1 atom coordination. This explanation is
consistentwith theQFR structurewith theUQ-analogue inhibitor (DNP-
19) that shows the predicted shift in its ring position [8]. These ﬁndings
also point out that it would be beneﬁcial if X-ray structures were
available with UQbound inwild-type QFR or the FrdCGlu29Leumutant
enzyme. In summary, a distinct feature of the Q-site in QFR is strong
quinone-binding at the O1 carbonyl that provides an axis for Q to rotate
in and out of the Q-site within the same plane of the benzo- or
napthoquinone rings similar to themotion of a pendulumasmodeled in
Fig. 3.
The X-ray structure for SQR shows no direct contact between the
O4 carbonyl of UQ and the proposed H-donor Ser C27 [6].Computational and structural studies have suggested that the position
where UQ is boundmay not be the actual site where UQ intermediates
are stabilized during catalysis [29]. Mutagenesis and kinetic data have
demonstrated the importance of Ser C27, Arg C31, and Asp D82
[38,41] and the computational data [29] modeled UQ deeper into the
quinone-binding pocket so that it makes contact with Ser C27 and His
B207 in what was proposed as the catalytic position. The model was
conﬁrmed structurally by the location of the potent quinone-site
inhibitors atpenin A5 and carboxin [29,30] which make H-bond
contact with the Ser C27 and His B207. As for the movement of the
quinone described above for QFR the quinone moves to the catalytic
site with a pendulummotion as the benzoquinone ring O1 carbonyl is
anchored by Trp B164 and Tyr D83 that enables the swinging
movement. The mechanism for UQ reduction by SQR, thus involves
the binding of UQ at the entry of the Q-site (shown in green on the
right side of Fig. 3), and upon reduction of the redox chain by
succinate, UQ swings into its catalytic position (shown in blue on the
right of Fig. 3). An enabling factor in this swinging motion appears to
be through the 3-methoxy group of UQ which forms an H-bond to His
B207 to possibly stabilize the ubisemiquinone radical [29,38]. These
structural studies agree with previous studies showing that modiﬁ-
cation of the 2- or 3-methoxy groups of the benzoquinone ring affect
the activity of bovine SQR [42]. In those studies there was a complete
loss of activity when either methoxy group was substituted by a
methyl group [42]. More recently it has been shown that the 2-
methoxy group of ubiquinone is essential for the quinone acceptor
function in reaction centers from Rhodobacter sphaeroides [43]. The
reaction center was the ﬁrst membrane protein for which primary and
distal positions for quinones were observed at the Qb-site [23,24].
When UQ is bound at the stand-by position it makes a single H-bond
to the protein but upon formation of the semiquinone at the Qa-site
the quinone rotates and ﬂips into the catalytic position where
multiple H-bonds including many to methoxy groups are established
[23,24,43]. Thus, it is worth suggesting that the methoxy substituents
of the quinone head groups play an important role in catalysis in
general. First, it is known that the dihedral angle of methoxy groups
on benzoquinones can have an impact on the redox potential of the
quinone and on catalytic activity with proteins [43–45]. Second,
methoxy groups may be critical for movement into the catalytic
position and/or for stabilization of the semiquinone intermediates
during redox reactions [29,43]. Third, methoxy groups may be
important for catalysis by participating in coordination of catalytic
water(s) for H+-exchange. The latter suggestion helps to explain the
retention of signiﬁcant catalytic activity in the E. coli SdhD Tyr83
mutants [38], in contrast to the yeast enzyme where different
substitutions of the equivalent residue resulted in only a minimal
retention of catalytic activity [39]. The conserved waters seen in the E.
coli, avian, and pig SQR structures [6,7,15,30] are coordinated by
several H-bonds from protein, as well as, from the 2-methoxy group of
UQ. Thus, conserved water may play a role in catalysis as either a
direct H+-donor to the O1 oxygen atom of the benzoquinone in the
native protein or substitute for Tyr D83 in the mutant enzymes. These
ﬁndings are in agreement with a recent mutagenesis study of
potential water coordinating amino acids in E. coli SQR [46].
Further characterization of the dynamics of quinone movement
during catalysis is needed in order to fully deﬁne the quinone-binding
site of complex II. Overall the studies of the quinone-binding site of
both SQR and QFR show that there is signiﬁcant interplay between the
protein, the solvent, and the quinone itself in order for complex II to
be proﬁcient in catalysis.Acknowledgements
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